Spannabis B2B
News
Cannabis business news.
- German medical cannabis gets cheaper: prices down 31%
Median price per gram falls 31% in Germany as potency rises and imports slow 15%. What it means for the European cannabis industry. - CBD Novel Food: EFSA sets the EU’s first safe limit
EFSA sets a provisional safe CBD level (~2 mg/day) as a novel food: what it now demands from Europe’s cannabidiol industry and what changes. - Medical cannabis in Spain: the AEMPS registry opens the door to the industry
Royal Decree 903/2025 is now operational: the standardized preparations registry is live and the first compounded formulation is typified. What it means for producers, labs and distribution. - Europe’s cannabis is ‘more potent and complex’: key points from the 2026 European Drug Report
The EU drugs agency EUDA puts the number of adults who used cannabis last year at 25 million and warns of resin averaging 24.6% THC. What it means for the industry. - Spain consolidates its position as a medical cannabis export power
Spain produced 51.3 tonnes of cannabis in 2024 (+42.5%) and ranks among the world’s eight largest producers, yet its new medical framework keeps domestic access tightly restricted. - Europe’s medical cannabis accelerates: Germany sets the pace
Europe confirms itself as the engine of the global medical cannabis market in 2026: Germany absorbs 62% of Canadian exports as oversupply and new frameworks grow.